Tag: Health

  • Google starts highlighting virtual care options in Search and Maps

    The COVID-19 pandemic has put a spotlight on virtual care options as both doctors and patients try to reduce in-person visits for routine care as much as possible. Patients aren’t always aware of what’s available to them, though, so over the course of the next two weeks, Google will roll out new features in Search and Maps that will highlight telehealth options.

    Hospitals, doctors and mental health professionals can now add details about their virtual care offerings to their Business Profile in Search and Maps, for example. When a patient then searches for them, they’ll see a “get online care” link that will take them to their provider’s website with more information.In the U.S., Google will also start showing virtual care platforms when people use search queries like “immediate care.” The search results page will now highlight both in-person and virtual care options, something that wasn’t previously the case. Uninsured users will also see more details about out-of-pocket prices for their visits.
    In addition, Google will now also automatically try to surface a link to a healthcare provider’s COVID-19 page, where they can highlight their own policies for walk-in visits or updates to their operating hours, for example.
    Source: TechCrunch

  • AIIMS Issues Guidelines About The Right Way To Disinfect PPE Kit To Fight Against Covid-19

    AIIMS Issues Guidelines About The Right Way To Disinfect PPE Kit To Fight Against Covid-19

    Due to the continuous increase in the coronavirus epidemic, in India where the number of infected cases has reached 5,916 and 178 people have died, the demand for PPE i.e. personal protective equipment has also increased rapidly and this is the reason why these security devices have fallen drastically short in the market.

    AIIMS issues new guidelines for treatment of Covid-19 cases - Coronavirus  Outbreak News

    Because 30-40% of the pharmaceutical items and equipment are imported from China and other countries, due to the lockdown and the coronavirus crisis there has been a huge loss of trade across the world. In such a situation, AIIMS has issued guidelines for the reuse of PPE in the wake of the coronavirus outbreak. Also, it is emphasized that PPE is usually used only once and then discarded. Because such kits are now barely available in the market, ways are being given to disinfect the kit.

    AIIMS: PPE Kit should be used only once:

    According to AIIMS guidelines, the reuse of the PPE kit is not being promoted at this time, as it affects the performance of the respirator. However, if these kits are disinfected and reused, the existing kit can be used for a longer period of time.

    PPE kits for women: Affordable choices that you can buy online | Most  Searched Products - Times of India

    AIIMS stated, “The COVID-19 epidemic has severely affected our resources in healthcare settings. One of the most important issues is the rapid lack of personal protective equipment (PPE) used in the care of patients.”

    This is a major concern for the health and safety of health workers. Healthcare workers across the country have exposed PPE deficiencies several times, including cover heels, protective glasses, masks, gloves, and shoe covers.

    Ways to disinfect the PPE equipment kit

    Over 50,000 PPE Kits Sent By China To India Unsafe, Unusable: Report

    According to AIIMS guidelines, coveralls and N95 masks can be disinfected using a doubling of 11 percent hydrogen peroxide vapor in a sealed room. At the same time, face shields and protective glasses can be cleaned by adding 0.5 percent sodium hypochlorite solution and 70 percent alcohol.

    So far 178 people have died due to the Coronavirus in India and this dangerous infection has killed about 89,416 people across the world. So, it has been advised to be careful and to maintain social distancing and to stay at home.

     

     

     

  • Headspace appoints former Intuit exec CeCe Morken as president and COO

    As it looks to continue along its path of developing clinically validated digital therapeutics for consumer and clinical mental health and wellness, Headspace has bulked up its executive team with the addition of longtime Intuit executive, CeCe Morken.

    Morken will become the company’s first president and chief operating officer, joining the Los Angeles based, billion-dollar-valued, mental wellness after spending thirteen years at Intuit .
    She previously served as Executive Vice President and General Manager of that company’s strategic partner group.
    Morken has spent the past thirty five years at technology companies and will be reporting directly to the company’s co-founder and chief executive, Rich Pierson.
    Her operational experience will come in handy as Headspace continues to develop both commercial and clinical products to bring to market, Pierson said.
    “We are thrilled to welcome to CeCe, a team-oriented and purpose-driven leader, to the Headspace team,” said Pierson in a statement. “We feel so lucky that the company is in a position to attract someone with the deep experience that CeCE has in scaling world-class organizations.”
    While on the surface there may not appear to be much similarity between a massive, decades-old accounting software development behemoth and a ten-year-old startup which has made its name focused on mental wellness, Pierson said that as Headspace expands it would require the skills that Morken developed over decades in operational roles at her previous company.
    Headspace is already a giant in the mental wellness category. It counts over 62 million users around the world and its Headspace for work service is being rolled out as a service for employees at companies like Adobe, General Electric, Hyatt, and Starbucks. The company has research underway in over ten clinical trials to move from mental wellness into the digital health category, under its Headspace Health subsidiary, which launched in 2018.
    Source: TechCrunch

  • Why telehealth can’t significantly flatten the coronavirus curve—yet

    The COVID-19 pandemic rages on.

    As cases in the United States skyrocket, one of the most foreboding possibilities of COVID-19’s rapid growth is the potential to overwhelm hospital capacity. Hospitals in cities like New York are already underwater, relying on hospital boats (“70,000 ton message[s] of hope and solidarity”) to keep them afloat, and on retired providers as well as prematurely graduated medical students to staff those beds.
    In tandem, telehealth has rapidly evolved from a “nice to have” to a “need to have” for U.S. health systems.

    Telehealth: from hype to hope to here, overnight

    This timing is prescient, as the technologies for telehealth have existed for several decades (at varying levels of sophistication) with modest uptake to-date. From 2005 to 2017, only one out of every 150 doctor visits and one in every 5,000-10,000 specialist visits were conducted via telemedicine.
    A major catalyst to uptake was the federal government’s announcement two weeks ago that restrictions on the use of telehealth for Medicare would be temporarily lifted. That policy change included expanding coverage across specialties and settings; waiving co-payments; and loosening HIPAA privacy requirements (such as prohibiting ubiquitous teleconferencing technologies like Apple’s FaceTime).
    Accordingly, telehealth—overnight(ish)—is finally mainstream.
    At America’s largest health systems, adoption of telehealth has accelerated rapidly: at Massachusetts General Hospital, the weekly number of virtual appointments has multiplied 10-20 times in the past weeks, while at NYU Langone Health, staffing was increased fivefold to handle the rush of new appointments. Teladoc, the U.S.’s largest virtual-care provider, is now reporting over 100,000 appointments weekly.

    The diversification of telehealth use cases

    The proliferation of telehealth via pioneering health systems has spawned unique use cases rarely seen before in the landscape of U.S. healthcare.
    These use cases cut across numerous settings: emergent care, intensive care, triage, and monitoring, to name a few. Outside the hospital setting, domestic initiatives such as Houston’s Project Emergency Telehealth and Navigation (ETHAN) has provided a precedent for the use of telemedicine by paramedics and EMTs in first-response. These sorts of programs have actively been pioneered by startups such as RapidSOS in response to COVID-19.
    At the gateway to the hospital (the emergency room), building on work by Jefferson Hospital in Philadelphia, health systems including Kaiser Permanente, Intermountain Health, and Providence Health have adopted programs for tele-intake to minimize contact between providers and patients under investigation (PUIs) for COVID-19.
    Upon admission to the hospital, telehealth is being used for monitoring patient status while also ensuring the safety of health providers. Such technologies are proving exceptionally important given wide-scale shortages of personal protective equipment (PPE).
    At Washington State’s Providence Regional Medical Center Everett (the site of the first COVID-19 case in America), programs for telemonitoring of ICU patients were built from the ground up in six weeks. Startups like EarlySense are combining multimodal sensors with audiovisual capabilities to enable remote detection and evaluation of clinical deterioration on non-intensive wards.
    Following discharge from the emergency room or the inpatient units of the hospital, telescreening tools like TytoCare are enabling physicians to conduct exams and deliver care remotely that previously would have required in-person contact. In the case of discharge from the emergency room—given the volatile clinical course of COVID-19—methods for streamlined and regular check-ins are critical to monitor symptoms and guide the need for more intensive treatment.
    Likewise, given recovery from the disease can potentially be tumultuous (especially after ICU care), these technologies are essential for mitigating what has been deemed the “post-hospital syndrome” and ensuring long-term health after discharge from inpatient care.

    Here—but there, or everywhere?

    While the near-overnight expansion of telehealth in diverse forms is positive news, barriers remain to its widespread dissemination in this country. To move from the prototyping stage at the meccas of modern medicine to a widely useful tool across healthcare settings, telehealth must seek to solve what has been deemed the “last mile problem.”
    The last mile refers to the non-technological, practical elements of local care delivery. As with telehealth, when these practical elements of care delivery are inadequately addressed, they inhibit providers from implementing new technologies for patients. In the case of telehealth, the last mile can be grouped into four domains: those related to (a) coverage and reimbursement (b) legal concerns (c) clinical care and (d) social challenges. The federal government’s policy change this month took major steps forward to resolve some legal concerns, including limitation of tort liability and allowing common teleconferencing platforms that may not be strictly HIPAA compliant.
    However, considerable obstacles to the uptake of telehealth persist across the other three domains, especially for the 86.5% of Americans not on Medicare. To effectively combat COVID-19, telehealth must also reach these 281 million individuals in the under-resourced nooks and crannies of the U.S. As the virus becomes more pervasive across the country, rural health systems are depending heavily on these technologies to manage the imminent surge of cases.

    The essentials to expanding telehealth

    In terms of coverage for patients, only 36 states mandated coverage of telehealth services in insurance plans as of April 2019. For those with mandatory coverage, out-of-pocket copays typically ranged $50-80 per appointment. Alternatively, certain plans waived copays, but only following an annual fee for premium services—premiums which may well rise going forward.
    All of these costs will hinder the use of telehealth in non-Medicare patients amidst the present outbreak.
    While in the past two weeks, some private insurers such as United Healthcare (covering 45 million Americans), Humana (39 million), and Aetna (13 million) waived copays on telehealth services, the privates covering the remaining hundreds of millions of Americans must follow quickly. States can help accelerate this by following the lead of Massachusetts, which last month required all insurers to cover telehealth.
    In terms of reimbursement to providers, only 20% of states required payment parity for telehealth to ensure—if telehealth was covered at all—it is remunerated at rates approximating in-person visits for similar diagnoses. This disparity has made adoption of telehealth undesirable and/or untenable for health systems, since the reimbursement rates for telehealth average 20-50% lower than for comparable in-person service.
    The challenges to adoption of telehealth are further heightened for independent practices, who must pay subscription fees to use standard telehealth platforms, but simultaneously experience revenue decreases of some 30% upon integrating telehealth. To make adoption of telehealth financially feasible for health systems and individual practices amidst the COVID-19 outbreak, states once again should follow Massachusetts in seizing the opportunity to enforce payment parity by private insurers.
    Finally, in terms of clinical care, issues abound in the minutia of how and where telehealth can be performed. In terms of how telehealth is performed: while these services should integrate with the existing workflows of clinical practice, insurance rules currently hinder this. For example, e-visits and check-ups are only permitted for “existing” patients rather than for new patients presenting with mild symptoms or fleeting concerns, who may not require a full work-up (this is the case even under the recent CMS policy).
    Moreover, asynchronous methods such as “store-and-forward” consultations and remote patient monitoring—exactly the sort of efficient and highly-scalable pathways integral to the flexible provision of care to the dispersed masses—are restricted in most states.
    Additionally, where telehealth can be conducted is hamstrung by “origination site” policies banning these services in patient homes but for a select few conditions (such as stroke assessment and opiate rehabilitation). Such arbitrary, excessive regulations make the widespread utilization of telehealth unrealistic. Also, state-by-state licensing requirements prevent physicians from providing care across borders (for reasons rooted in nineteenth-century concerns of medical quality gaps between states).
    To promote the care of COVID-19 patients in epicenter regions, states should follow the lead of New York and Florida to suspend out-of-state licensing bans, allow license transferability, or at least expedite licensing through “licensure compacts” in allied states.
    Finally, in terms of social challenges, considerable access disparities exist between demographic groups. For example, according to the National Telecommunications and Information Administration’s 2018 survey, vulnerable populations such as the elderly were 21% less likely to have internet access and almost 50% less likely to conduct videocalls; the poor were 34% less likely to communicate with doctors online; and other demographic minorities (such as Hispanic ethnicity or lower educational attainment) were also less likely to have access to and/or use telehealth technologies.
    Since these populations are more likely to face the sorts of comorbid conditions and social determinants of health that heighten mortality from COVID-19—and less likely to have levels of health literacy allowing them to reduce their risk of transmitting infectious diseases like coronavirus—inequalities in telehealth access bear important implications on the country’s ability to flatten the curve of COVID-19.
    One of the single best interventions to augment access for these individuals is expanding the scope of practice of non-physician health providers. These providers have their wings clipped by arcane laws fiercely defended by state medical associations that require their “supervision” by physicians for most cases of patient care. This is despite analyses since the 1980s exhibiting the capability for non-physician healthcare providers (such as nurse practitioners and physician assistants) to provide services as high quality as those of physicians.
    Liberating various allied health practitioners (including also registered nurses, pharmacists, dentists, paramedics, and social workers) to screen, diagnose, treat, and prescribe with increased autonomy would undergird telehealth’s capabilities as a “force multiplier” in the setting of COVID-19. They can also unleash the potential of startups such as The MAVEN Project which provide platforms for peer-to-peer consults between specialty and generalist health providers in emergency settings.
    In geographically dispersed states such as California—where allied health providers are expected to provide half of all primary care appointments by 2030—these policies are especially vital. Bills designed to facilitate these programs like the California Assembly Bill 890 that remains stalled should be endorsed to protect patients across the state from the insidious diffusion of COVID-19.
    In summary, the early responses by federal and state agencies to COVID-19 have made progress to promote the uptake of telehealth. However, as the virus expands its siege across the country, more comprehensive solutions are urgently needed to equip the creators, users, and beneficiaries of telehealth with the arsenal they desperately require to vanquish this invisible enemy. Accordingly, pen-and-paper may be the most important technologies for bolstering telehealth today. Letters to senators, in the near-term, may be the most potent ammunition we’ve got.
    Source: TechCrunch

  • Lockdown – It is not comfortable to work from home, threat towards health issues

    All efforts are being made by the government and society to stop the spread of coronavirus. In this, social distancing is considered to be the most effective effort. Social distancing means staying away from others and staying at your home as much as possible. Because of this, millions of employees of companies from all over the world are working from home. However, many employees who work from home also describe it as beneficial, Like there is no hassle of getting up in the morning to get ready for office. There is no problem with the dress code of any kind. There is no alarm bell, there is a very flexible schedule where the work of the office goes on with giving time at home. There is no doubt that currently, the practice of work from home is popular. According to recent figures, approximately 4.3 million employees work from home. You may find the idea of working from overwhelming as you don’t have to wake up early in the morning and start working without any dress code, but sitting in a room all day can affect your health.

    Difficult to manage personal and professional life?

    Many people want to keep their professional and personal lives separate. However, this is not possible in case of Work from Home. Also, you may have to work on your holiday as well. You work for 8-9 hours in the office, in which you have to go through a variety of activities, but at home, you are busy in office work in any corner along with that you need to take care of household activities. In such a situation, you have to manage both otherwise which makes your work more terrible. Working from home has become quite challenging especially for women. 

    HR Shreya Verma of a private company says that she has to manage the housework as well as office work. There is a shift to work in the office, but since she is working at home, she has been working more than the shift. She now works for 11-12 hours instead of 9 hours.

    At the same time, Anurag Mishra, who works in an IT company based in Gurugram, says that work from home has become a problem for him too. His workload has increased more than before, due to which the pressure has increased significantly and stress is a major to lead to various health problems. These days he has to work for 12 to 15 hours. He says, while working from home, one has to be online all the time, sometimes on a video conference or sometimes co-ordinate over the phone. Meanwhile, children and families do not spend much time with them.

    Afraid of ending social life?

    You have to meet different people for 8 hours of work in the office, you discuss over the tea/coffee with your office friends. You cannot do all this during work from home. At home, you are confined between the walls, between family and office work you are unable to give time to yourself, your friends, because of this fear of ending social life.

    Know what health experts say?

    Talking to senior doctor Rakshit Garg Mani Bhaskar of Delhi Government Hospital- Lok Nayak Jai Prakashan Narayan Hospital (LNGP) says that the work from home has increased the immense pressure. Routines have deteriorated in everything from food and drink to stress levels of employees.

    Dr. Rakshit says, we come across five to six such cases every day, which explains the problem of eye pain due to working from home. At the same time, according to Safdarjung’s doctor Reena Mittal, these days people are not able to get out, in such a situation, they said that such people should work according to a routine where they can focus on household work, office work and also health.

    According to the doctors, to be healthy, do at least 30 minutes of exercise daily. If there is a complete lockdown in your area or you have kept yourself in isolation, don’t get out of the house. In this case, exercising a little at home will digest food and bones will be healthy. This will also remove the problem of body pain.

  • CDC is expected to tell Americans to wear cloth masks, save medical masks for health workers

    On Thursday, the White House said that it will likely soon adjust previous guidelines that discouraged non-health workers from wearing face masks. The change would be issued as “guidance” from the CDC, but according to the president—who continues to hesitate at exerting federal power during the COVID-19 crisis—it will not be made mandatory.

    Supplies of medical-grade masks are still running critically low in many places hard hit—or soon to be hard hit—by the coronavirus. Due to ongoing shortages, the new guidance is expected to concern cloth and non-medical face coverings only.
    In Thursday’s White House press briefing, Dr. Deborah Birx, coronavirus task force response coordinator, stressed that the updated guidance was an “additive” protective measure and not meant as a substitute. “When the advisory comes out… if it comes out… it will be an additive piece,” Birx said.
    Birx suggested that the White House and CDC hesitated to offer the new mask advice due to concerns that people would relax critical social distancing measures that will prove key to U.S. containment efforts.”We don’t want people to feel like ‘oh i’m wearing a mask, I’m protected and I’m protecting others.’”
    As Birx explained the thinking behind the new precaution of cloth masks, Trump offered his own unfounded interpretation of the information. “If people wanted to wear them, they can,” Trump said. “In many cases, the scarf is better, it’s thicker” he added, incorrectly.
    The new guidance is expected in the coming days and will come from the Centers for Disease Control and Prevention (CDC). In memos obtained by the Washington Post, the CDC began considering the cloth mask recommendation due to evidence that people without symptoms are transmitting the virus. A draft copy of the policy states that the CDC “… recommends the community use of cloth masks as an additional public health measure people can take to prevent the spread of virus to those around them.”
    On Wednesday, Los Angeles Mayor Eric Garcetti urged residents to cover their faces in public while making a point to stress that N95 and surgical masks go straight to medical workers.

    A grassroots effort of crafters is already springing up around the country to create home-sewn masks for health workers unable to get proper PPE and others who want to take the protective measure. Many online resources offer patterns and how-to resources on mask construction and even no-sew methods. New federal recommendations around cloth masks could also provide an opportunity for businesses to offer helpful resources in the fight against COVID-19, as many companies make creative moves to stay afloat.
    While mask-wearing is routine even outside of pandemic times in countries like Japan and South Korea, Western countries are generally less comfortable with the practice. Social norms may be compounded by confusing messaging from officials who urged Americans to donate medical masks to health workers at the same time as suggesting the masks do not provide protection against the virus in everyday situations.
    “Seriously people- STOP BUYING MASKS!” U.S. Surgeon General Jerome Adams tweeted in late February. “They are NOT effective in preventing general public from catching #Coronavirus, but if healthcare providers can’t get them to care for sick patients, it puts them and our communities at risk!”
    That messaging may have proved expedient in the earliest days of the crisis as Americans hoarding masks for personal use could worsen an already constricted supply of personal protective equipment for medical personnel.
    Cloth masks are less effective than medical masks, but their use, even if imperfect, is better than nothing at helping limit the spread of the virus. In one prescient small 2013 study examining the efficacy of homemade masks in the event of a flu pandemic, researchers recommended cloth masks “be considered only as a last resort… but it would be better than no protection.”
    That research, published by Cambridge University Press, found that both homemade cloth masks and traditional surgical masks “significantly” reduced the amount of potentially infectious droplets expelled by the wearer, though surgical masks were three times better for preventing transmission. Because homemade masks are less disposable than medical masks, they should be washed after use to get rid of infectious droplets.
    On Thursday, health officials were careful to stress that using a mask does not mean that it’s okay to relax physical distancing measures.
    “Just remember it’s not a substitute for everything that we’re asking people to do!” Birx said.
    Source: TechCrunch

  • ImmunityBio and Microsoft team up to precisely model how key COVID-19 protein leads to infection

    An undertaking that involved combining massive amounts of graphics processing power could provide key leverage for researchers looking to develop potential cures and treatments for the novel coronavirus behind the current global pandemic. Immunotherapy startup ImmunityBio is working with Microsoft’s Azure to deliver a combined 24 petaflops of GPU computing capability for the purposes of modelling, in a very high degree of detail, the structure o the so-called “spike protein” that allows the SARS-CoV-2 virus that causes COVID-19 to enter human cells.

    This new partnership means that they were able to produce a model of the spike protein within just days, instead of the months it would’ve taken previously. That time savings means that the model can get in the virtual hands of researchers and scientists working on potential vaccines and treatments even faster, and that they’ll be able to gear their work towards a detailed replication of the very protein they’re trying to prevent from attaching to the human ACE-2 proteins’ receptor, which is what sets up the viral infection process to begin with.
    The main way that scientists working on treatments look to prevent or minimize the spread of the virus within the body is to block the attachment of the virus to these proteins, and the simplest way to do that is to ensure that the spike protein can’t connect with the receptor it targets. Naturally-occurring antibodies in patients who have recovered from the novel coronavirus do exactly that, and the vaccines under development are focused on doing the same thing pre-emptively, while many treatments are looking at lessening the ability of the virus to latch on to new cells as it replicates within the body.
    In practical terms, the partnership between the two companies included a complement of 1,250 NVIDIA V100 Tensor Core GPUs designed for use in machine learning applications from a Microsoft Azure cluster, working with ImmunityBio’s existing 320 GPU cluster that is tuned specifically to molecular modeling work. The results of the collaboration will now be made available to researchers working on COVID-19 mitigation and prevention therapies, in the hopes that they will enable them to work more quickly and effectively towards a solution.
    Source: TechCrunch

  • Researchers to study if startup’s wrist-worn wearable can detect early COVID-19 respiratory issues

    It’s highly unlikely that the current coronavirus crisis will be neatly and fully “solved” by any one endeavor or solution, which makes new studies like one involving startup WHOOP’s wrist-worn fitness and health tracking wearable all the more important. The study, conducted by the Central Queensland University Australia (CQUniversity), in partnership with the Cleveland Clinic, will employ data collected by WHOOP’s hardware from hundreds of volunteers who have self-identified as having contracted COVID-19 to study changes in their respiratory behavior over time.

    The data to be used for this study has been collected from WHOOP’s 3.0 hardware, which has also recently been validated by a University of Arizona external study conducted specifically to determine the accuracy of its measurement of respiratory rates during sleep, which the device uses to provide quality of sleep scores to its users. That study showed it to be among the most accurate measurement tools for respiratory rate short of invasive procedures, which is what has led researchers behind this new study to hypothesize that it could be valuable as a sort of early-warning system for detecting signs of abnormal respiratory behavior in COVID-19 patients before those symptoms are detectable by other means.
    The WHOOP team says that the respiratory rate its hardware reports very rarely deviates from an established individual baseline, and that when it does so, it’s usually due to either one of two causes: environmental factors, like unusually high temperatures or significant differences in oxygen concentration, or something happening within the body, like a lower-respiratory tract infection.
    COVID-19 is specifically a lower-respiratory tract infection, unlike the flu or a cold, which are upper-respiratory issues. That means there’s a strong correlation between rate changes due to lower-respiratory tract issues not accounted by environmental problems (which are relatively easy to cancel out) and instances of COVID-19. And because the WHOOP wearable is designed to look for deviations as a sign of distress, among the other sings it monitors, it could notice changes to respiratory rates relative to baselines before an individual becomes aware of any significant shortness of breath themselves.
    This is a study, so at this point that’s just a hypothesis, and will need to be backed up by data. The team behind it says it should take around six weeks, and there are an “initial several hundred self-reported COVID-19 cases” already present in the app from which it will begin, with a target of enrolling at least 500 individuals with positive COVID-19 test results. There are also other investigations underway to see if wearables that monitor a user’s health and fitness can provide early warning systems for potential COVID-19 cases, including a study being conducted by UCSF using the Oura Ring.
    Unlike with previous pandemics, the current coronavirus crisis comes at a time when we’re increasingly used to taking data-driven approaches to solving challenges, and when we also have a lot of self-quantifying health devices in circulation. Those could help us get a better grip on assessing the spread, as well as trends related to how it circulates and ebbs/grows within a population.
    Source: TechCrunch

  • Operation COVID-19 will allow self-reporting of cases, to get ahead of official figures

    The Canadian founder of a startup who caught COVID-19 from Justin Trudeau’s wife has launched an initiative to allow anyone to self-report their own case of the disease and publish the results, helping authorities to get ahead of the pandemic.

    Operation COVID-19 will visualize both official and suspected cases of the Coronavirus in data lists and on a map, with the aim of saving lives and improving global public health systems. People will be able to self-report the case via an anonymous questionnaire.
    The site aims to demonstrate how many official tests — compared to suspected COVID-19 cases — there are.
    “The more people who can contribute their COVID-19 experiences, we can turn the table on this pandemic and build more intelligence to save lives,” said co-founder Jillian Kowalchuk.
    Kowalchuk is cofounder of “street-smart” safety app Safe & The City, but fell ill with COVID-19 symptoms after meeting the Prime Minister of Canada’s wife, Sophie Trudeau — who later tested positive for the disease — on March 5th at Canada House in London, as she Instagrammed.
    She was later dismayed to learn she was refused a test for COVID-19 in a UK hospital and was instead told to go home and self-isolate, making her concerned about the lack of testing and public awareness of the scale of the problem.
    “First-hand experiences like this are becoming more common throughout the world as more are refused testing, leaving the majority of COVID-19 cases unknown, under-estimating the severity of the problem, limiting preventative measures and resource mobilization into other needed public health monitoring systems,” she told TechCrunch .
    The initiative will collect insights from people who have contracted COVID-19 to provide back to the medical and public health authorities.
    In doing so it will create a map visualization of both official and self-reported COVID-19 cases, recovered and deaths to support best practices globally, including more testing.
    To contribute software development to the project you can access its GitHub here or volunteer by emailing [email protected] or joining the Facebook group.
    Source: TechCrunch

  • FDA introduces a new program to expedite deployment of potential coronavirus treatments

    The U.S. Food and Drug Administration (FDA) announced a new program today that’s designed to foster close collaboration between public and private organizations in order to “bring coronavirus treatments to market as fast as possible,” according to U.S. Department of Health & Human Services Secretary Alex Azar in a press release. The program, dubbed the “Coronavirus Treatment Acceleration Program,” or CTAP, will see the FDA redeploy resources and personnel with an eye toward providing private companies, researchers and scientists with “regulatory advice, guidance and technical assistance as quickly as possible.”

    Based on the information provided by the agency, it sounds like CTAP is a formalization of a lot of the work that was already being done within the FDA to reduce the burden placed on companies and scientists looking to field trials and the steps required by the administration to qualify new treatments and therapies for use.
    In real-world terms, the FDA says that means it’s turning things around much more quickly, reviewing protocols for many freshly submitted clinical studies within 24 hours, and also turning around single-patient requests for expanded access to some therapies granted under compassionate or investigate use “generally within three hours.” The FDA is also looking at how it can build out streamlined protocols that can apply across use by different institutions and for different programs wherever possible to further limit processing time through templated strategies.
    Internally, the FDA has re-arranged staffing resources to help make this possible, putting medical and regulatory staff that otherwise would be focused elsewhere on teams dedicated to COVID-19-related reviews.
    There’s likely to be some debate about the implications of the introduction of a program like this. On the one hand, it should help novel approaches and even startups in the biotech space with unproven, but promising technologies in development to work hand-in-hand with the FDA on potential solutions. On the other hand, the administration has already been criticized for some of its more aggressive decisions regarding COVID-19 therapeutics, including the Emergency Use Authorization ordered for anti-malarial hydroxychlroquine earlier this week.
    While small-scale studies have shown that the drug could offer some benefit in the treatment of COVID-19 patients, the key word there is “could,” and other small-scale studies have shown that standard anti-viral treatments are just as effective. The bottom line is that there isn’t enough data available to say anything definitively either way, and this particular EUA means that efforts to stockpile the drug could make it less available to those who use it for another of its common purposes: treating chronic rheumatoid arthritis, which can be debilitating in its severity.
    The current coronavirus pandemic is unprecedented in terms of its spread and impact, at least in terms of viral outbreaks during the modern medical era. The FDA definitely needs to address the situation in a unique manner as a result, but critics and observers will definitely be watching to see what results from increased pressure on the agency to cut red tape.
    Source: TechCrunch